RVTY
Revvity, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$131.40
+0.59%Forward multiples
Based on analyst estimates
- P/E forward
- 23.31x
- P/E 2026E
- 24.30x
- P/E 2027E
- 22.11x
- P/E 2028E
- 20.06x
- P/S forward
- 5.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- 62.57x
- PEG TTM
- 0.37x
- Price / book
- 2.03x
- Price / sales
- 5.04x
- Price / cash flow
- 23.32x
Enterprise value
- Enterprise value
- $17.0B
- EV / sales
- 5.83x
- EV / EBITDA
- 22.14x
- EV / EBIT
- 47.32x
- Market cap
- $14.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026